16 May 2018 - Deborah Wilkes
Archived
Recordati said its OTC business had generated 16.4% of sales in the first quarter of 2018, but declined to comment on a Reuters report that it had recently held takeover talks with a private-equity firm.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.